The present invention pertains to novel
dibenzo[b,f]oxepine-10-carboxamides compound to a process for the
preparation of such compounds of formula I, their use as a
pharmaceuticals, especially in the treatment of neurological and vascular
disorders related to beta-amyloid generation and/or aggregation, and to
pharmaceutical compositions and combinations comprising such compounds of
formula I.